SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Emile Griffith Synthetic CCD

PatientEmile Griffith
Date of birth1959-02-03
IdentifiersMRN HR-BX005-SYN; SSN (made up) 000-05-6418
Document date2026-11-01
AuthorCeleste Fairbanks-Ochieng, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care with his care partner for memory loss and confusion: cognitive testing, reversible causes, PTSD and depression screening with a safety assessment, falls, and the plan. Concerns: He wants to know why he forgets things and wants to keep living at home; He still dreams about the fight in which his opponent died and wants the nightmares to ease; His care partner worries about him getting lost and about managing as things change. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 25 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-05-05 to 2026-06-16completedS
Sertraline 50 mg oral tablet, one tablet each morningOne tablet each morningOral route2026-06-16activeS

Procedures

ProcedureDatesStatusEvidence
MRI of the brain without contrast, with susceptibility-weighted imaging: mild generalized atrophy, slightly more in the frontal lobes, with hippocampi in the normal range for age (medial temporal atrophy score 1 on each side); a small area of old injury (encephalomalacia with hemosiderin) at the tip of the right frontal lobe; seven microbleeds at the gray-white junction of both frontal lobes; a few small white matter hyperintensities (Fazekas 1); a cavum septi pellucidi; no infarct, mass, subdural collection or hydrocephalus2026-05-19 to 2026-05-19completedS
Neuropsychological testing, about three hours with breaks: slowed processing speed and reduced attention, set-shifting and verbal fluency; learning and free recall reduced but much better with cues and recognition (a retrieval pattern rather than rapid forgetting); naming, language and visual perception intact; consistent with mild cognitive impairment of frontal-subcortical type; effort measures valid; mood and PTSD symptoms noted as contributors2026-06-10 to 2026-06-10completedS
Cognitive processing therapy for PTSD with the clinic psychologist: twelve weekly sessions, adapted for memory problems (shorter sessions, written one-page summaries, phone reminders, and his care partner helping with practice between sessions, with his consent)2026-05-26 to 2026-08-11completedS
Advance care planning conversation, about 30 minutes, with him and his care partner; his capacity to name a health care agent and state his values was assessed and present2026-08-04 to 2026-08-04completedS
Physical therapy for balance and strength: ten sessions with a home exercise program (sit-to-stand, heel raises, tandem stance, walking program)2026-06-23 to 2026-09-01completedS

Immunizations

DateVaccineStatusEvidence
2025-10-14High-dose influenza vaccine, 2025-2026 seasoncompletedS
2026-08-04Pneumococcal conjugate vaccine PCV20completedS
2026-08-04Recombinant zoster vaccine, dose 1 of 2completedS
2026-10-27High-dose influenza vaccine, 2026-2027 seasoncompletedS
2026-10-27Recombinant zoster vaccine, dose 2 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1958 to 1977Professional boxing from 1958 to 1977, 112 bouts over nineteen years: long exposure to repetitive head impacts; no source read records a count of knockouts or losses of consciousnessD (CLM-0002, CLM-0003)
March 24, 1962Title fight in 1962 after which his opponent died ten days later; lifelong nightmares and distress about it, in his own public wordsD (CLM-0004, CLM-0005)
1992Severe beating by a group of men in 1992, one with a baseball bat, with several months in hospital, much of it in intensive care; short-term memory problems reported sinceD (CLM-0008, CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He wants to know why he forgets things and wants to keep living at homeactiveS
He still dreams about the fight in which his opponent died and wants the nightmares to easeactiveS
His care partner worries about him getting lost and about managing as things changeactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.1 on 2026-05-05; Hemoglobin [Mass/volume] in Blood 14.2 on 2026-05-05; Platelets [#/volume] in Blood by Automated count 228 on 2026-05-05; Sodium [Moles/volume] in Serum or Plasma 137 on 2026-09-15; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-05-05; Creatinine [Mass/volume] in Serum or Plasma 1 on 2026-05-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 82 on 2026-05-05; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-05-05; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-05-05; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 418 on 2026-05-05; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-05-05; Total score [MoCA] 22 on 2026-05-05; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 2026-08-04; PC-PTSD-5 score [PC-PTSD-5] 4 on 2026-05-05; PTSD PCL-5 score [PCL-5] 20 on 2026-10-27; Clinical Dementia Rating scale [CDR] 0.5 on 2026-05-19; Total score [AUDIT-C] 2 on 2026-08-04; Cholesterol [Mass/volume] in Serum or Plasma 186 on 2026-08-04; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 2026-08-04; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 2026-08-04; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-08-04; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-08-04 [S]

Strengths and supports: Strengths and supports: warmth, humor and generosity, pride in his career and in the fighters he trained, his care partner, family on the islands and in New York, and friends from boxing [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be foundresolvedconfirmed R41.3S — Synthetic presenting problem anchored to the documented short-term memory problems; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.
Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41activeconfirmed F43.12S — Synthetic modern diagnosis at intake by clinical interview against DSM-5-TR criteria, anchored to his public words about lifelong nightmares; not a historical diagnosis.
Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excludedactiveconfirmed G31.84S — Synthetic modern diagnosis at the third visit after MRI and neuropsychological testing; anchored to the documented memory problems and pugilistic dementia, not a retrospective diagnosis of his real illness.
Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospitalactiveconfirmed Z87.820S — Synthetic coding of the documented career and assault.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-05Leukocytes [#/volume] in Blood by Automated count6.110*3/uL4-11 10*3/uLNormalS
2026-05-05Hemoglobin [Mass/volume] in Blood14.2g/dL13.5-17.5 g/dLNormalS
2026-05-05Platelets [#/volume] in Blood by Automated count22810*3/uL150-400 10*3/uLNormalS
2026-05-05Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-05-05Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-05-05Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.74-1.35 mg/dLNormalS
2026-05-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M82mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-05Glucose [Mass/volume] in Serum or Plasma94mg/dL70-140 mg/dLNormalS
2026-05-05Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-05-05Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma418pg/mL232-1245 pg/mLNormalS
2026-05-05Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-05-05Total score [MoCA]22{score}S
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-05-05PC-PTSD-5 score [PC-PTSD-5]4{score}S
2026-05-05PTSD PCL-5 score [PCL-5]41{score}S
2026-05-19Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-05-19Clinical Dementia Rating scale [CDR]0.5{score}S
2026-06-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-06-16PTSD PCL-5 score [PCL-5]37{score}S
2026-09-15Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-09-15PTSD PCL-5 score [PCL-5]26{score}S
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-27PTSD PCL-5 score [PCL-5]20{score}S
2026-08-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-08-04Total score [AUDIT-C]2{score}S
2026-08-04Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=199 mg/dLNormalS
2026-08-04Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-08-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-08-04Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-08-04Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-05Body height170cmS
2026-05-05Body weight74kgS
2026-05-05Body mass index (BMI) [Ratio]25.6kg/m2S
2026-05-05Systolic blood pressure134mm[Hg]S
2026-05-05Diastolic blood pressure80mm[Hg]S
2026-05-05Heart rate70/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.7CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-19Body height170cmS
2026-05-19Body weight73.8kgS
2026-05-19Body mass index (BMI) [Ratio]25.5kg/m2S
2026-05-19Systolic blood pressure130mm[Hg]S
2026-05-19Diastolic blood pressure78mm[Hg]S
2026-05-19Heart rate68/minS
2026-05-19Respiratory rate14/minS
2026-05-19Body temperature36.6CelS
2026-05-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-16Body height170cmS
2026-06-16Body weight73.6kgS
2026-06-16Body mass index (BMI) [Ratio]25.5kg/m2S
2026-06-16Systolic blood pressure128mm[Hg]S
2026-06-16Diastolic blood pressure78mm[Hg]S
2026-06-16Heart rate68/minS
2026-06-16Respiratory rate14/minS
2026-06-16Body temperature36.6CelS
2026-06-16Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-15Body height170cmS
2026-09-15Body weight73.9kgS
2026-09-15Body mass index (BMI) [Ratio]25.6kg/m2S
2026-09-15Systolic blood pressure128mm[Hg]S
2026-09-15Diastolic blood pressure76mm[Hg]S
2026-09-15Heart rate66/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.7CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-27Body height170cmS
2026-10-27Body weight74.2kgS
2026-10-27Body mass index (BMI) [Ratio]25.7kg/m2S
2026-10-27Systolic blood pressure126mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate66/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-04Body height170cmS
2026-08-04Body weight73.8kgS
2026-08-04Body mass index (BMI) [Ratio]25.5kg/m2S
2026-08-04Systolic blood pressure126mm[Hg]S
2026-08-04Diastolic blood pressure76mm[Hg]S
2026-08-04Heart rate66/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-05-05Establishing care with his care partner for memory loss and confusion: cognitive testing, reversible causes, PTSD and depression screening with a safety assessment, falls, and the planfinishedS
2026-05-19Two-week review, seen the same day by cognitive neurology: brain MRI, staging, traumatic encephalopathy syndrome and other causes, sertraline and sodiumfinishedS
2026-06-16Six-week review: neuropsychological testing, the diagnosis and the plan, PTSD treatment, safety and caregiver supportfinishedS
2026-09-15Four-month review: PTSD after cognitive processing therapy, mood, sodium, falls and caregiver strainfinishedS
2026-10-27Six-month review: PTSD, mood, cognition, safety and the plan for the year aheadfinishedS
2026-08-04Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Cognitive work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression and PTSD screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a medicine review for anticholinergic and sedating drugs, a sleep apnea screen, hearing and vision checks, and brain MRIcompletedGL-ALZ-2024, GL-ALZ-PC-2024, GL-CMID-2026S
Cognitive neurology consultation at the memory clinic to stage the impairment, weigh traumatic brain injury, traumatic encephalopathy syndrome, Alzheimer's disease, vascular disease and the effects of PTSD and depression, and choose further testingcompletedGL-ALZ-2024, GL-TES-2021S
PTSD treatment by shared decision: cognitive processing therapy with the clinic psychologist, weekly for about twelve sessions, adapted for memory problems; and sertraline 25 mg each morning, raised to 50 mg after four to six weeks if tolerated, with sodium checked two weeks after starting and after the increase; benzodiazepines avoidedcompletedGL-PTSD-2023, GL-BEERS-2023S
Collaborative safety plan with warning signs, coping steps, people to call, the clinic number and the 988 Suicide & Crisis Lifeline; medicines kept by his care partner; PHQ-9 item 9 and safety reviewed at every visitcompletedGL-SUICIDE-2024, GL-PTSD-2023S
Falls: STEADI assessment, physical therapy for balance and strength with a home program, and a home safety checkcompletedGL-STEADI, GL-CMID-2026S
Measurement-based care: PCL-5 and PHQ-9 at each chronic-care visit during treatment; MoCA yearly or sooner with change; medicine review every visitcompletedGL-PTSD-2023, GL-CMID-2026, GL-ALZ-2024S
After the diagnosis: no cholinesterase inhibitor or memantine, which are not shown to help mild cognitive impairment or traumatic brain injury; memory strategies (one calendar, phone reminders, a fixed daily routine), exercise, social activity, sleep and blood pressure care; repeat neuropsychological testing in twelve to eighteen months or sooner with change; Alzheimer's disease biomarker testing explained and declined for now, as it would not change his carecompletedGL-ALZ-2024, GL-TES-2021, GL-CMID-2026S
Travel and money safety: carry a card with his address and his care partner's number, share his phone location, travel with company on unfamiliar routes, and set up shared oversight of billscompletedGL-ALZ-2024S
Caregiver support: education about mild cognitive impairment and PTSD, the Alzheimer's Association 24/7 Helpline (which serves all causes of cognitive impairment), a caregiver class and a burden check; the Medicare GUIDE model explained for if dementia develops latercompletedGL-ALZ-2024, GL-GUIDES
Advance care planning while he can take part fully: a health care agent, his values and goals of care, at the annual wellness visitcompletedGL-ALZ-2024, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Find the cause of the memory problems and explain it to him in a way he can take in2026-06-16completedMild cognitive impairment most likely due to traumatic brain injury; explained with his care partner present, at his request, with a written summaryS
A clinically meaningful fall in PTSD symptoms (PCL-5 down at least 10 points) by four months2026-09-15completedPCL-5 from 41 to 26 after cognitive processing therapy and sertralineS
Nightmares no more than about once a week, with at least six hours of sleep most nights2026-10-27completedNightmares about once every two weeks; sleeping about six and a half hoursS
No falls, with a balance and strength program2026-10-27completedNo falls; Timed Up and Go from 13 to 10 seconds after physical therapy and a home programS
Name a health care agent and record his goals of care while he can take part fully2026-08-04completedHealth care agent named and goals of care recorded at the annual wellness visitS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-05-05: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, medicines kept by his care partner, and a two-week follow-up; safety reviewed at every visit [S]